Chemotherapy and Targeted Therapy for Endocri...

Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be offered—including scenarios where tissue biopsies are challenging, unsafe, or una ...  Afficher plus

Dr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment strategies for patients with advanced NSCLC and EGFR mutations, including classical EGFR alterations ( ...  Afficher plus

Fill up with delicious practice-changing knowledge food from #SGIM22 as The Curbsiders team discusses breast cancer survivorship, sexual dysfunction, How climate change will affect health, Are PT consults necessary in the hospital?, Do we need antibiotics for aspiration events?, ...  Afficher plus

Knowledge bomb: Prostate cancer. Everything you need to know from a Naturopathic/Functional perspective. In this episode, hormone and prostate cancer expert Dr. Ralph Esposito gives us the low down on all things prostate health. When do we begin taking care of our prostate? How d ...  Afficher plus

Quelle voie d’abord privilégier ? Faut-il faire une exérèse de l’uretère distal ?Faut-il faire une ligature première de l’uretère ?Faut-il faire un curage ganglionnaire ? Faut-il faire une IPOP ?Le Dr Xylinas (CHU Bichat, Paris) répond à toutes vos questions ! L’orateur n’a pas r ...  Afficher plus

AF conversion in the ED, HRT, a shining example of evidence-based medicine and less-is-more, multimorbidity, and what's coming at AHA are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. <u>To rea ...